Only a qualified medical professional can determine if tirzepatide is the right choice for your unique needs
Multivariate analysis showed no difference between placebo and liraglutide arms in HbA1c at 6 months (HbA1c:0.2 mmol/mol, 11.3, 11.6, p = 0.98) however, at 12 months HbA1c was significantly higher in the liraglutide arm (HbA1c:10.9 mmol/mol, 1.1, 20.6, p = 0.032)
This regulatory shift has implications for availability and pricing
As the science continues to evolve, were seeing that these benefits may extend to people who dont necessarily need to lose weight, and thats opened up an interesting conversation about why people are microdosing GLP-1 medications
Tight clothing over the site is also best avoided
This supplementary section provides clinicians with practical tools, strategies, and recommendations for interprofessional management of hyperkalemia of adult outpatients with CKD and diabetes who have a compelling indication for RAASi therapy